RhumbLine Advisers’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-606,023
Closed -$537K 2988
2022
Q4
$537K Buy
606,023
+48,432
+9% +$42.9K ﹤0.01% 2431
2022
Q3
$875K Buy
557,591
+34,728
+7% +$54.5K ﹤0.01% 2209
2022
Q2
$1.05M Buy
522,863
+213,161
+69% +$428K ﹤0.01% 2115
2022
Q1
$722K Buy
309,702
+5,297
+2% +$12.3K ﹤0.01% 2270
2021
Q4
$1.42M Buy
304,405
+5,653
+2% +$26.3K ﹤0.01% 2063
2021
Q3
$2.28M Buy
298,752
+7,335
+3% +$56K ﹤0.01% 1837
2021
Q2
$2.82M Buy
291,417
+8,903
+3% +$86.3K ﹤0.01% 1772
2021
Q1
$2.34M Sell
282,514
-11,518
-4% -$95.2K ﹤0.01% 1841
2020
Q4
$2.01M Buy
294,032
+44,853
+18% +$306K ﹤0.01% 1844
2020
Q3
$2.78M Sell
249,179
-14,082
-5% -$157K ﹤0.01% 1507
2020
Q2
$1.65M Buy
263,261
+100,296
+62% +$630K ﹤0.01% 1835
2020
Q1
$300K Sell
162,965
-809
-0.5% -$1.49K ﹤0.01% 2408
2019
Q4
$554K Buy
163,774
+6,998
+4% +$23.7K ﹤0.01% 2316
2019
Q3
$336K Buy
156,776
+1,140
+0.7% +$2.44K ﹤0.01% 2523
2019
Q2
$416K Buy
155,636
+16,188
+12% +$43.3K ﹤0.01% 2438
2019
Q1
$662K Buy
139,448
+1,811
+1% +$8.6K ﹤0.01% 2201
2018
Q4
$330K Buy
137,637
+54,072
+65% +$130K ﹤0.01% 2491
2018
Q3
$368K Buy
83,565
+3,873
+5% +$17.1K ﹤0.01% 2410
2018
Q2
$574K Buy
+79,692
New +$574K ﹤0.01% 2242
2017
Q2
Sell
-34,686
Closed -$137K 2972
2017
Q1
$137K Buy
34,686
+2,686
+8% +$10.6K ﹤0.01% 2736
2016
Q4
$157K Buy
32,000
+1,725
+6% +$8.46K ﹤0.01% 2729
2016
Q3
$234K Buy
30,275
+300
+1% +$2.32K ﹤0.01% 2602
2016
Q2
$168K Buy
29,975
+575
+2% +$3.22K ﹤0.01% 2811
2016
Q1
$158K Buy
29,400
+230
+0.8% +$1.24K ﹤0.01% 2810
2015
Q4
$254K Buy
29,170
+4,110
+16% +$35.8K ﹤0.01% 2672
2015
Q3
$210K Buy
25,060
+1,110
+5% +$9.3K ﹤0.01% 2763
2015
Q2
$422K Buy
+23,950
New +$422K ﹤0.01% 2443